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Abstract
Malignant melanoma is the most common primary malignant tumour arising on the foot. Where
improvements in the prognosis have been observed for patients with melanoma elsewhere on the
skin, pedal lesions are still frequently delayed in presentation through neglect or misdiagnosis.
Detection of foot melanoma relies on the health care practitioner's skills and observations in
recognising early changes. Recent publications have documented the use a dermoscopy as a tool
to improve recognition of such suspicious lesions. This paper reviews current literature with a
special emphasis of its potential applications on plantar and nail unit melanoma. Data from these
studies suggest that the technique is a useful and significant adjunct to clinical examination, which
ultimately may lead to earlier recognition of this aggressive tumour.
Introduction
Cancers involving the skin account for a third of all
human cancers. According to the World Health Organisa-
tion, malignant melanoma (MM) accounts for an esti-
mated 132 000 new cases annually and around 66 000
deaths. Globally the incidence of the disease continues to
rise, particularly in Caucasian populations [1]. As there is
no effective treatment for the disease, improving survival
still remains around earlier detection of malignant
lesions. The thinner the lesion at diagnosis, the better the
prognosis [2]. There is some evidence to suggest that
patients are presenting earlier and that the mean
melanoma thickness at diagnosis is declining [3],
although risk factors such as older age, male gender and
low educational level still predict higher thickness at pres-
entation [4-6].
Melanoma and the foot
Malignant melanoma is the most common primary,
malignant tumour of the foot [7] accounting for between
3–15% of all cutaneous melanoma [8]. Whereas improve-
ments have been seen in the prognosis for some patients
with melanoma, pedal lesions are still a major concern.
The three most common types occurring on the foot are
the superficial spreading (figure 1), nodular and acral len-
tiginous melanoma (ALM – figure 2). ALM is particularly
prevalent on the foot as it has a predilection for the soles
and nail unit [9]. In addition, it is a sub-type of melanoma
that affects all skin types [10]. Day [11] identified MM on
the foot as an independent risk factor for disease recur-
rence. This was examined further by Hsueh and colleagues
[12] who reviewed 652 cases of cutaneous melanoma and
analysed data comparing anatomical location to survival
rates. Controlling for other variables including tumour
thickness, their results confirmed that primary melanoma
on the foot had a 5 year survival rate of 77% compared
with 94% and 95% for lesions on the calf and thigh
respectively. They concluded that the prognosis deterio-
rated the further the lesion was from the trunk.
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From the available data, the reason for this is not clear but
is probably less likely to do with the physical nature of the
tumour and more to do with delays in presentation and
diagnosis. Prognosis, in part, is worsened in foot
melanoma as lesions frequently present later and are
therefore thicker at diagnosis [13]. Reasons for patient
delays have been well studied [5,14-17]. Richard et al
studied 590 melanoma patients and reported a number of
factors that predicted thicker lesions including melanoma
which were out of the patients view (such as the plantar
surface of the foot). From a medical perspective longer
physician delays in diagnosis have also been observed
with acral lesions [18]. Misdiagnosis could also explain a
reduced prognosis in patients with acral melanoma.
Bristow and Acland [19], reviewing 27 cases of acral len-
tiginous melanoma on the foot suggested a misdiagnosis
rate of 33% whilst other workers have reported much
higher rates of up to 60% in melanomas of the foot [20].
Metzger and co-workers [21] in a review of delayed diag-
nosis of melanoma highlighted that many acral
melanoma are initially presented to non-dermatologists
because patients do not suspect the problem to be a
melanoma. As such clinicians are less aware of the condi-
tion; mis-diagnosis would be more of an issue. Illustrating
this, many papers have been published highlighting foot
melanoma misdiagnosed as other conditions such as fun-
gal infection, onychomycosis, ulceration, haematoma and
other more common foot pathologies [20,22-27].
Detection of melanoma
The value of educating patients and practitioners through
melanoma awareness campaigns cannot be emphasized
too strongly and various initiatives have tried to heighten
the public awareness and monitoring of skin. Equally
important is the role of the practitioner in screening
patients – physician detected melanomas have been
shown to be significantly thinner at diagnosis than those
detected by patients [6]. The ABCD rule, devised in 1985
by Freidman [28] has been well used as a mnemonic in
skin assessment for recognising change in melanocytic
naevi. Its value in foot melanoma has been questioned as
acral lesions do not exhibit the typical features of malig-
nant melanoma elsewhere on the skin [19,21]. Therefore
at a clinical level, the decision to monitor, excise or refer
on a suspicious lesion can be a difficult one.
Dermoscopy
Visual examination of a suspicious skin lesion such as a
melanoma can be significantly enhanced by the addition
of surface microscopy. This was first recognised by Scot-
tish Dermatologist Rona MacKie who in 1971 published
a paper which demonstrated pre-operatively, the high pre-
dictive value of close examination of melanoma [29]. The
difficulty arises however in that evaluation of the skin
under normal conditions, with a standard magnifier, is
limited due to surface reflection and refraction. To over-
come this the dermatoscope is a simple, and relatively
cheap, hand held magnifying device (typically 10×) which
uses an oil medium or cross-polarised light allowing the
viewer to observe structures deeper in the skin, not nor-
mally visible to the naked eye (figure 3). Since the 1980's
the idea of "dermoscopy" began to gain momentum and
its popularity as a tool aiding clinical decision making
increased, particularly in Europe as more research evi-
dence was published. In 1990, around 13 papers were
published; in 2007 it had risen to over 500.
It should be emphasized that the dermatoscope itself is
not a diagnostic tool but acts to aid decision making in
when confronted with a suspicious lesion, allowing the
practitioner greater confidence when deciding whether to
refer, excise or leave a skin lesion.
Superficial spreading melanoma on the ankle Figure 1
Superficial spreading melanoma on the ankle.
Acral lentiginous melanoma Figure 2
Acral lentiginous melanoma.Journal of Foot and Ankle Research 2009, 2:14 http://www.jfootankleres.com/content/2/1/14
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The use of the dermatoscope was initially the exclusive
realm of the dermatologist, experimental and early work
gave rise to extensive descriptions of patterns and features
visualised in melanocytic naevi, melanoma and other skin
tumours. This then moved to the formalisation of the
technique into various algorithms such as pattern analysis
[30], the 7-point technique [31], the modified ABCD tech-
nique [32] and the Menzies method [33]. Two early meta-
analyses of the dermatoscopic technique were published
concluding that it increases sensitivity and specificity for
the diagnosis of melanoma when compared to the naked
eye when in the hands of an experienced clinician [34,35].
In 2004, it was recognised that in order to achieve a
decrease in morbidity and mortality, dermoscopy should
be a screening test that is available to all practitioners
involved in skin screening providing it was accurate, easily
to apply and inexpensive. Such a test would have the aim
of highlighting suspicious lesions earlier and allow the
practitioner to refer patients onto a specialist for further
evaluation [36]. Using a randomised controlled trial
methodology Westerhoff and colleagues [37] demon-
strated it was possible to train a group of non-dermatol-
ogy expert general practitioners and significantly improve
their clinical recognition skills compared with a control
group. Argenziano et al [38] reported similar findings
with a cohort of 73 primary care physicians. In the UK,
courses have been running for a number of years and
include a range of health care practitioners. The most
recent meta analysis of dermoscopy [36] has encom-
passed a review of literature including those studies con-
ducted on practitioners with minimal training in the
technique and has still concluded a relative diagnostic
odds ratio for dermoscopy compared with naked eye
examination to be 15.6 (CI 95%; 2.9–83.7, p = 0.01). It
therefore seems pertinent to explore the technique as an
extension of scope of practice within podiatry. To date the
authors are unaware of any published literature docu-
menting its application within this profession.
The three point technique
The three point technique was developed by Soyer et al
[36] who recognised that dermoscopy could be a screen-
ing tool for all those involved in skin care. As a result it is
a simplified technique to screen suspicious lesions and it
particularly useful for the novice. Through the dermato-
scope, it assesses individual lesions on three criteria:
(i) Asymmetry of colour and dermatoscopic structures
(ii) Presence of an atypical network
(iii) Presence of blue-white structures or veil
Each criterion, if present scores 1 point. Any lesions scor-
ing two or above should be considered for biopsy and
warrant possible excision. A summary of the technique
can be found in table 1. A preliminary study of 231 pig-
mented skin lesions showed that after one hours training
six inexperienced dermatologists were able to improve
their sensitivity in recognising skin cancer from 69.7% to
96.3% [39]. In a later study with 150 participants, Soyer
[36] demonstrated 91% sensitivity, with those in the
cohort declaring no experience in dermoscopy still achiev-
ing 87% sensitivity for melanoma. Further studies are
required to confirm this finding.
Dermoscopy and the foot
The dermatoscope has been found useful for the examina-
tion of the skin, but the foot has offered a particular chal-
lenge to the technique, firstly, because of its thickened
acral plantar surface which gives an altered presentation
of pigmentation [40] and secondly the nail unit which fre-
quently presents with pigmentation due to a range of
causes including haematoma and melanoma. On plantar
Dermatoscopes Figure 3
Dermatoscopes.
Table 1: The three point checklist [36]
Feature Significance
Asymmetry Examined in both axes, using the dermatoscope. Colour and structures are assessed. Significant 
asymmetry of colour or structures within the lesion are recorded as a score of 1.
Atypical pigment network Many naevi have a uniform reticular pattern to the pigment distribution resembling chicken wire or a 
honeycomb structure with regular brown or black lines. An atypical network is recorded as a score of 
1 if the network is irregular in thickness, irregular holes, or irregular colours.
Blue structures or blue-white veil The presence of any blue structure observed including a blue-white veil scores 1.
Any lesion scoring two or more should warrant further investigation – referral/excisionJournal of Foot and Ankle Research 2009, 2:14 http://www.jfootankleres.com/content/2/1/14
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(and palmar) skin the blue-white veil is rarely observed
although asymmetry of colour and shape should still be
considered.
In addition, other dermatoscopic observations of acral
and volar skin have been reported. Saida, Myazaki and
colleagues identified 3 specific pigment patterns deter-
mined as normal in benign melanocytic naevi of plantar
skin parallel furrow, lattice-like and fibrillar pattern [41-
44] (figure 4). In each of these the pigment is located in
the furrows of the plantar dermatoglyphics. The patterns
arise as a reflection of normal melanin columns in the
stratum corneum in a vertical (parallel furrow) or slanting
fashion [40].
Malignant melanoma has been shown to exhibit different
patterns on the palmar and plantar surfaces. Saida [42]
and workers reported, in concordance with the three point
algorithm asymmetry and irregular (variegate) colour was
a common feature. Furthermore, in malignant melanoma
pigmentation is frequently accentuated on the ridges of
the dermatoglyphics and not furrows as in benign lesions
[45] (Figure 5). To test the hypothesis Saida and col-
leagues [46] reviewed 712 melanocytic lesions in acral
areas, to determine the specificity and sensitivity of these
patterns in determining the presence of malignant
melanoma. The parallel ridge pattern showed a positive
predictive value of 93.7% (the proportion of patients with
a proven melanoma who exhibited a parallel ridge pat-
tern) and in benign melanocytic lesions the positive pre-
dictive value of the parallel furrow pattern and lattice like
pattern were very high at 93.2% and 98.3% respectively
(the proportions of patients diagnosed with a benign
melanocytic naevus who showed the parallel furrow pat-
tern). The study was carried out on a Japanese cohort
although later studies have confirmed the findings in Cau-
casian populations [47,48].
Dermoscopy and its potential in assessing nail 
pigmentation
In addition to the application of the dermatoscope in
assessing pigmented plantar lesions, its utility in assessing
nail pigmentation has been discussed [49]. A patient pre-
senting with longitudinal melanonychia always presents a
diagnostic challenge to Podiatrists due to its various
causes such as ethnicity, drugs, trauma and occasionally
melanoma. Biopsy of such lesions has the potential to
cause permanent scarring to the nail unit. Ronger et al
[50] discussed the role of the dermatoscope in nail pig-
mentation and suggest it as a tool to decide if a nail biopsy
should be performed. Subsequent publications have
Dermatoscopic features of benign melanocytic naevi on  plantar skin (after Miyazaki et al [44]) Figure 4
Dermatoscopic features of benign melanocytic naevi 
on plantar skin (after Miyazaki et al [44]).
Pattern Image Location 
Parallel furrow  Observed mainly on the margins of the 
weightbearing surfaces, pigmentation is 
observed in the furrows 
Lattice-like pattern  Arch areas and non-weightbearing volar areas, 
pigmentation is observed in the furrows with 
links crossing like rungs on a ladder 
Fibrillar pattern  Weight bearing areas (particularly heels, 
forefoot and pulps of the toe), pigmentation is 
observed in the furrows with fine parallel 
streaks crossing the dermatologlyphics 
tangentially
Melanin distribution patterns on acral skin Figure 5
Melanin distribution patterns on acral skin.
Benign melanocytic naevus: melanoctyes are 
frequently clustered in the areas below the furrows of 
the plantar dermatoglyphics 
Malignant melanoma: melanoctyes and pigmentation 
extends and is accentuated onto the dermatopglyphic 
ridges of the plantar skin Journal of Foot and Ankle Research 2009, 2:14 http://www.jfootankleres.com/content/2/1/14
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explored this concept further. Braun and colleagues [51]
describe the dermatoscopic features of the different causes
of melanonychia and have proposed an algorithm. In a
similar manner Jellinek [52] suggests it has a role in
assessing nails prior to biopsy and again proposes an algo-
rithm. Neither of these have been formally tested to iden-
tify their true validity but with time one would expect
further development in this area as experience increases.
Conclusion
Current evidence still demonstrates a rise in the incidence
of melanoma, the most lethal form of skin cancer. With-
out an effective treatment, early detection and excision are
vital to improve the prognosis and survival. Lesions
located on the foot have been shown to be prone to more
diagnostic delays and misdiagnosis compared with
tumours elsewhere on the body, subsequently resulting in
a poorer prognosis. Dermoscopy is a simple and inexpen-
sive means of visualising pigmented lesions and has been
shown to improve diagnostic accuracy. Although origi-
nally considered a technique for specialist dermatologist,
later developments have suggested that the dermatoscope
can be a useful screening tool for health care professionals
involved in skin care. On this basis, dermoscopy is poten-
tially a new extension to the scope of practice in Podiatry.
In theory, podiatric practice would be well suited for
screening pedal lesions. Many patients are routinely seen,
particularly the elderly (the age group where most
melanoma are observed). The addition of dermoscopy at
initial patient assessment may increase not only practi-
tioner awareness but also offer an excellent opportunity to
discuss self examination with patients and reinforce the
public health message. In its short history the dermato-
scope has shown to be effective in highlighting melanoma
whilst reducing excisions of benign lesions, but its true
capabilities are still being discovered. Continued research,
in time, should uncover its true potential.
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